Home/ Supplements/ Electrolytes/ DenxiBone Formula

DenxiBone Formula

product on market Tablet or Pill CATALO Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 27% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains calcium, magnesium, and zinc, which are minerals supported by strong evidence for maintaining bone density and structural integrity. Aquamin provides a bioavailable source of these minerals to support skeletal health. Overall, the evidence coverage for this specific ingredient combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for DenxiBone Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
27%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Aquamin
2000 mg
Aquamin
200 mg
Calcium
600 mg
110 mg
Within RDA (0.3× RDA) 316 studies (A:8, B:159)
8 mg
Within RDA (0.7× RDA) 263 studies (A:6, B:134)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
Energy
3 Kcal(s)
Total Fat
0.2 Gram(s)
Carbohydrates
0.3 Gram(s)
Protein
Sodium
7 mg

Other Ingredients

Dicalcium Phosphate Stearic Acid Cellulose Magnesium Stearate Croscarmellose Sodium Silicon Dioxide Hydroxypropyl Cellulose Hypromellose Polyethylene Glycol Wax, Micronized Talc
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Serving Directions For age 12 or above, take 1-2 tablets daily. For pregnant and lactating women, take 1 tablet twice daily. Take after meal.

Formulation Notes

Extra Bone Support Promotes Bone Health Clinically Proven Ingredient Sourced from nature

CATALO DenxiBone Formula contains unpolluted red algae calcium from Iceland, together with natural marine magnesium, it provides natural calcium, magnesium, zinc and marine minerals which are essential elements for building bone structures and prevent calcium loss. The plant source sustainable algae is proven to improve joint mobility by strengthening bone structure and integrity. Unlike calcium extracted from limestone, CATALO DenxiBone Formula has a high bioavailability and will not lead to adverse effect like bloating and constipation. With Vitamin D3 added, it further enhances bone formation and calcium absorption, thus improves bone density. 1. Shea, K.L., et al. (2014) Med Sci Spot Exerc. 46(10), 2007-2013 (Refer to Aquamin Sea Algae Powder) 2. Frestedt, J.L., et al. (2008) Nutr. J., 7(9) (Refer to Aquamin Sea Algae Powder) Aquamin is a trademark of Marigot Ltd.

Main Functions: Strengthen bone tissue and structure Improve bone density and tenacity Relieve joint pain and promote mobility Reduce bone loss Improve muscle strength

Suitable for: Teenagers, adults, elderlies, pregnant and lactating women, lack outdoor activity, concern about bone and joint health

Made in USA

Additional Information

Storage Keep in a dry and cool place. Avoid direct sunlight.

Certified Good Manufacturing Practices cGMP

Net weight 83g (1384mg x 60 tablets)

Metadata

Product Details

DSLD Entry Date2023-11-22
Product TypeOther Combinations
FormTablet or Pill
BrandCATALO
DSLD ID303044
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.